Kaplan AG. Chronic cough in adults: make the diagnosis and make a difference. Pulm Ther. 2019;5(1):11-21.
Michaudet C, Malaty J. Chronic cough: evaluation and management. Am Fam Physician. 2017;96(9):575-580.
Zeiger RS, Xie F, Schatz M. Prevalence and characteristics of chronic cough in adults identified by administrative data. Perm J. 2020;24:1-3.
Arinze JT, de Roos EW, Karimi L, Verhamme KMC, Stricker BH, Brusselle GG. Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study. ERJ Open Res. 2020;6(2):00300-02019.
Iyer VN, Lim KG. Chronic cough: an update. Mayo Clin Proc. 2013;88(10):1115-1126.
Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest. 1993;104(5):1511-1517.
Honkamäki J, Hisinger-Mölkänen H, Ilmarinen P. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood. Respir Med. 2019;154:56-62.
Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):75S-79S.
Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):267-276.
Moayyedi P, Eikelboom JW, Bosch J. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 2019;157(3):682-691.e2.
Lai K, Chen R, Peng W, Zhan W. Non-asthmatic eosinophilic bronchitis and its relationship with asthma. Pulm Pharmacol Ther. 2017;47:66-71.
Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869-875.
Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605.
Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370:m3489.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.
Zhang J, Perret JL, Chang AB. Risk factors for chronic cough in adults: a systematic review and meta-analysis. Respirology. 2022;27(1):36-47.
Tarlo SM, Altman KW, French CT, Diekemper RL, Irwin RS. Evaluation of occupational and environmental factors in the assessment of chronic cough in adults: a systematic review. Chest. 2016;149(1):143-160.
Bepko J, Mansalis K. Common occupational disorders: asthma, COPD, dermatitis, and musculoskeletal disorders. Am Fam Physician. 2016;93(12):1000-1006.
Irwin RS, French CL, Chang AB, Altman KW. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153(1):196-209.
Yılmaz İ. Angiotensin-converting enzyme inhibitors induce cough. Turk Thorac J. 2019;20(1):36-42.
Ding H, Shi C, Xu X, Yu L. Drug-induced chronic cough and the possible mechanism of action. Ann Palliat Med. 2020;9(5):3562-3570.
Krüger K, Holzinger F, Trauth J, Koch M, Heintze C, Gehrke-Beck S. Chronic cough. Dtsch Arztebl Int. 2022;119(5):59-65.
Morice AH, Millqvist E, Bieksiene K. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136.
Gluckman TJ, Bhave NM, Allen LA. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of covid-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;79(17):1717-1756.
Visca D, Beghè B, Fabbri LM, Papi A, Spanevello A. Management of chronic refractory cough in adults. Eur J Intern Med. 2020;81:15-21.
Wright ML, Sundar KM, Herrick JS, Barkmeier-Kraemer JM. Long-term treatment outcomes after behavioral speech therapy for chronic refractory cough. Lung. 2021;199(5):517-525.
Chen R, Qiu Z, Lai K. 2019 ERS cough guideline: consensus and controversy. J Thorac Dis. 2020;12(12):7504-7514.
Malesker MA, Callahan-Lyon P, Madison JM, Ireland B, Irwin RS. Chronic cough due to stable chronic bronchitis: CHEST expert panel report. Chest. 2020;158(2):705-718.
Wamkpah NS, Peterson AM, Lee JJ. Curbing the cough: multimodal treatments for neurogenic cough: a systematic review and meta-analysis. Laryngoscope. 2022;132(1):107-123.
Morice AH, Menon MS, Mulrennan SA. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007;175(4):312-315.
Côté A, Russell RJ, Boulet LP. Managing chronic cough due to asthma and NAEB in adults and adolescents: CHEST guideline and expert panel report. Chest. 2020;158(1):68-96.
Randel A. ACCP releases guideline for the treatment of unexplained chronic cough. Am Fam Physician. 2016;93(11):950.
Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest. 2016;149(3):639-648.
Slovarp LJ, Jetté ME, Gillespie AI, Reynolds JE, Barkmeier-Kraemer JM. Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy. Lung. 2021;199(3):263-271.
Morice AH, Kitt MM, Ford AP. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study. Eur Respir J. 2019;54(1):1900439.
Smith JA, Kitt MM, Morice AH. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med. 2020;8(8):775-785.
Song WJ, Morice AH. Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res. 2017;9(5):394-402.
Morice AH, Millqvist E, Belvisi MG. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014;44(5):1132-1148.
Meltzer EO, Zeiger RS, Dicpinigaitis P. Prevalence and burden of chronic cough in the United States. J Allergy Clin Immunol Pract. 2021;9(11):4037-4044.e2.
Young EC, Smith JA. Quality of life in patients with chronic cough. Ther Adv Respir Dis. 2010;4(1):49-55.
Jin HJ, Kim CW. Understanding the impact of chronic cough on the quality of life in the general population. Allergy Asthma Immunol Res. 2020;12(6):906-909.
Koskela HO, Lätti AM, Purokivi MK. Long-term prognosis of chronic cough: a prospective, observational cohort study. BMC Pulm Med. 2017;17(1):146.
Hollingsworth HM. Wheezing and stridor. Clin Chest Med. 1987;8(2):231-240.
Meslier N, Charbonneau G, Racineux JL. Wheezes. Eur Respir J. 1995;8(11):1942-1948.
Shim CS, Williams MH. Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med. 1983;143(5):890-892.
- Patel PH, Mirabile VS, Sharma S. Wheezing. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK482454/
- Gong H. Wheezing and asthma. In: Walker HK, Hall WD, Hurst JW, eds. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Butterworths; 1990.
Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246.
Holden DA, Mehta AC. Evaluation of wheezing in the nonasthmatic patient. Cleve Clin J Med. 1990;57(4):345-352.
- Atanelov Z, Aina T, Amin B, Rebstock SE. Nasopharyngeal airway. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK513220/
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (2022 Update). https://ginasthma.org/gina-reports/
Turner RM, DePietro M, Ding B. Overlap of asthma and chronic obstructive pulmonary disease in patients in the United States: analysis of prevalence, features, and subtypes. JMIR Public Health Surveill. 2018;4(3):e60.
Gupta S. Diagnosing asthma and chronic obstructive pulmonary disease: importance of pulmonary function testing. Can Fam Physician. 2022;68(6):441-444.
Knight A. Managing the overlap of asthma and chronic obstructive pulmonary disease. Aust Prescr. 2020;43(1):7-11.
Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373(13):1241-1249.
- Leung C, Sin DD. Asthma-COPD overlap: what are the important questions? Chest. 2022;161(2):330-344.
Wurst KE, Kelly-Reif K, Bushnell GA, Pascoe S, Barnes N. Understanding asthma-chronic obstructive pulmonary disease overlap syndrome. Respir Med. 2016;110:1-11.
Cosío BG, Dacal D, Pérez de Llano L. Asthma-COPD overlap: identification and optimal treatment. Ther Adv Respir Dis. 2018;12:1753466618805662.
Weiss LN. The diagnosis of wheezing in children. Am Fam Physician. 2008;77(8):1109-1114.
Marini JJ, Pierson DJ, Hudson LD, Lakshminarayan S. The significance of wheezing in chronic airflow obstruction. Am Rev Respir Dis. 1979;120(5):1069-1072.
Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63(2):65-81.
Cockcroft DW. Environmental causes of asthma. Semin Respir Crit Care Med. 2018;39(1):12-18.
Forgacs P. The functional basis of pulmonary sounds. Chest. 1978;73(3):399-405.
Langan RC, Goodbred AJ. Office spirometry: indications and interpretation. Am Fam Physician. 2020;101(6):362-368.
Johnson JD, Theurer WM. A stepwise approach to the interpretation of pulmonary function tests. Am Fam Physician. 2014;89(5):359-366.
Jokerst C, Chung JH, Ackman JB. ACR Appropriateness Criteria® Acute respiratory illness in immunocompetent patients. J Am Coll Radiol. 2018;15(11S):S240-S251.
Kirsch J, Wu CC, Bolen MA. ACR Appropriateness Criteria® Suspected pulmonary embolism: 2022 update. J Am Coll Radiol. 2022;19(11S):S488-S501.
Dempsey TM, Scanlon PD. Pulmonary function tests for the generalist: a brief review. Mayo Clin Proc. 2018;93(6):763-771.
Hodroge SS, Glenn M, Breyre A. Adult patients with respiratory distress: current evidence-based recommendations for prehospital care. West J Emerg Med. 2020;21(4):849-857.
Kelly AM, Holdgate A, Keijzers G. Epidemiology, prehospital care and outcomes of patients arriving by ambulance with dyspnoea: an observational study. Scand J Trauma Resusc Emerg Med. 2016;24(1):113.
Hall C, Nici L, Sood S, ZuWallack R, Castro M. Nonpharmacologic therapy for severe persistent asthma. J Allergy Clin Immunol Pract. 2017;5(4):928-935.
Singh SK, Tiwari KK. Bronchial thermoplasty: a non-pharmacological approach. Clin Respir J. 2017;11(1):13-20.
Campbell TG, Hoffmann TC, Glasziou PP. Buteyko breathing for asthma. Cochrane Database Syst Rev. 2018(8):CD009158.
Dombret MC, Alagha K, Boulet LP. Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults. Eur Respir Rev. 2014;23(134):510-518.
Castillo JR, Peters SP, Busse WW. Asthma exacerbations: pathogenesis, prevention, and treatment. J Allergy Clin Immunol Pract. 2017;5(4):918-927.
Oba Y, Keeney E, Ghatehorde N, Dias S. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2018(12):CD012620.
Falk NP, Hughes SW, Rodgers BC. Medications for chronic asthma. Am Fam Physician. 2016;94(6):454-462.
- Melani AS, Sestini P. Safety of long acting muscarinic antagonists: are all these drugs always and equally safe? Curr Med Res Opin. 2016;32(5):975-977.
Heffler E, Madeira LNG, Ferrando M. Inhaled corticosteroids safety and adverse effects in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(3):776-781.
Tsai CL, Delclos GL, Huang JS, Hanania NA, Camargo CA. Age-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol. 2013;110(4):240-246.e1.
Yáñez A, Cho SH, Soriano JB. Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J. 2014;7(1):8.
Hsu J, Chen J, Mirabelli MC. Asthma morbidity, comorbidities, and modifiable factors among older adults. J Allergy Clin Immunol Pract. 2018;6(1):236-243.e7.
Parshall MB, Schwartzstein RM, Adams L. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435-452.
Bowden JA, To THM, Abernethy AP, Currow DC. Predictors of chronic breathlessness: a large population study. BMC Public Health. 2011;11:33.
Budhwar N, Syed Z. Chronic dyspnea: diagnosis and evaluation. Am Fam Physician. 2020;101(9):542-548.
van Mourik Y, Rutten FH, Moons KGM, Bertens LCM, Hoes AW, Reitsma JB. Prevalence and underlying causes of dyspnoea in older people: a systematic review. Age Ageing. 2014;43(3):319-326.
Currow DC, Plummer JL, Crockett A, Abernethy AP. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage. 2009;38(4):533-545.
Stevens JP, Dechen T, Schwartzstein R. Prevalence of dyspnea among hospitalized patients at the time of admission. J Pain Symptom Manage. 2018;56(1):15-22.e2.
Campbell ML. Dyspnea prevalence, trajectories, and measurement in critical care and at life’s end. Curr Opin Support Palliat Care. 2012;6(2):168-171.
Grønseth R, Vollmer WM, Hardie JA. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610-1620.
Berliner D, Schneider N, Welte T, Bauersachs J. The differential diagnosis of dyspnea. Dtsch Arztebl Int. 2016;113(49):834-845.
Anaya JM, Rojas M, Salinas ML. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20(11):102947.
Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417.
Lopez-Leon S, Wegman-Ostrosky T, Perelman C. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.
Zhao YM, Shang YM, Song WB. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.
Wu X, Liu X, Zhou Y. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747-754.
Patel BV, Arachchillage DJ, Ridge CA. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202(5):690-699.
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.
Asadi-Pooya AA, Akbari A, Emami A. Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. 2021;46(6):428-436.
Waterer G. Recovery from community acquired pneumonia: the view from the top of the iceberg. Eur Respir J. 2017;49(6):1700571.
Mahler DA. Evaluation of dyspnea in the elderly. Clin Geriatr Med. 2017;33(4):503-521.
Baseline Dyspnea Index (BDI) & Transition Dyspnea Index (TDI). American Thoracic Society. https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/bdi-tdi.php
Ozkan M, Dweik RA, Ahmad M. Drug-induced lung disease. Cleve Clin J Med. 2001;68(9):782-785.
Jo T, Michihata N, Yamana H. Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study. Thorax. 2021;76(12):1193-1199.
Pinargote P, Guillen D, Guarderas JC. ACE inhibitors: upper respiratory symptoms. BMJ Case Rep. 2014;2014:bcr2014205462.
Daher A, Matthes M, Keszei A. Characterization and triggers of dyspnea in patients with chronic obstructive pulmonary disease or chronic heart failure: effects of weather and environment. Lung. 2019;197(1):21-28.
Liu PF, Yan P, Zhao DH. The effect of environmental factors on the differential expression of miRNAs in patients with chronic obstructive pulmonary disease: a pilot clinical study. Int J Chron Obstruct Pulmon Dis. 2018;13:741-751.
Bernhardt V, Babb TG. Exertional dyspnoea in obesity. Eur Respir Rev. 2016;25(142):487-495.
- Neborak JM, Nowalk NC, Mokhlesi B. The overlap of obesity-hypoventilation syndrome and obstructive sleep apnea: how to treat? Arch Bronconeumol. 2022;58(7):531-532.
Rare genetic disorders of the airways. https://clinicaltrials.gov/ct2/show/NCT00323167
National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention. Work-related respiratory diseases. https://wwwn.cdc.gov/eWorld/Set/Work-Related_Respiratory_Diseases/88
Sunjaya AP, Homaira N, Corcoran K, Martin A, Berend N, Jenkins C. Assessment and diagnosis of chronic dyspnoea: a literature review. NPJ Prim Care Respir Med. 2022;32(1):10.
Ferry OR, Huang YC, Masel PJ. Diagnostic approach to chronic dyspnoea in adults. J Thorac Dis. 2019;11(Suppl 17):S2117-S2128.
DeVos E, Jacobson L. Approach to adult patients with acute dyspnea. Emerg Med Clin North Am. 2016;34(1):129-149.
McComb BL, Ravenel JG, Steiner RM. ACR Appropriateness Criteria® Chronic dyspnea—noncardiovascular origin. J Am Coll Radiol. 2018;15(11S):S291-S301.
Dube BP, Dres M. Diaphragm dysfunction: diagnostic approaches and management strategies. J Clin Med. 2016;5(12):113.
Kiaee SZF, Rahimi B. Investigation of dyspnea using cardiopulmonary exercise test among patients resorting to the respiratory tests. Eur J Transl Myol. 2018;28(3):7556.
Bausewein C, Schunk M, Schumacher P, Dittmer J, Bolzani A, Booth S. Breathlessness services as a new model of support for patients with respiratory disease. Chron Respir Dis. 2018;15(1):48-59.
Farquhar MC, Prevost AT, McCrone P. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med. 2014;12:194.
Wirth KJ, Scheibenbogen C. Dyspnea in post-COVID syndrome following mild acute COVID-19 infections: potential causes and consequences for a therapeutic approach. Medicina (Kaunas). 2022;58(3):419.
George PM, Barratt SL, Condliffe R. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009-1016.
Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr. 2014;14:238.
- Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26(11):1448-1449.
Hui D, Kilgore K, Frisbee-Hume S. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. J Pain Symptom Manage. 2016;52(1):8-16.e1.
- Centers for Medicare & Medicaid Services. Medicare Coverage Database. National coverage determination: home use of oxygen, 240.2. https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=169
- Barnes H, Smallwood N. Pharmacological interventions for breathlessness-absence of effect or absence of evidence? JAMA Netw Open. 2021;4(2):e210262.
Wiseman R, Rowett D, Allcroft P, Abernethy A, Currow DC. Chronic refractory dyspnoea—evidence based management. Aust Fam Physician. 2013;42(3):137-140.
Massart A, Hunt DP. Management of refractory breathlessness: a review for general internists. J Gen Intern Med. 2021;36(4):1035-1040.
Frostad A, Søyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med. 2006;259(5):520-529.
Earwood JS, Thompson TD. Hemoptysis: evaluation and management. Am Fam Physician. 2015;91(4):243-249.
Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med. 2000;28(5):1642-1647.
Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ. 2009;339:b3094.
- Haponik EF, Fein A, Chin R. Managing life-threatening hemoptysis: has anything really changed? Chest. 2000;118(5):1431-1435.
O’Gurek D, Choi HYJ. Hemoptysis: evaluation and management. Am Fam Physician. 2022;105(2):144-151.
Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration. 2010;80(1):38-58.
Olsen KM, Manouchehr-Pour S, Donnelly EF. ACR Appropriateness Criteria® Hemoptysis. J Am Coll Radiol. 2020;17(5S):S148-S159.
Gagnon S, Quigley N, Dutau H, Delage A, Fortin M. Approach to hemoptysis in the modern era. Can Respir J. 2017;2017:1565030.
Larici AR, Franchi P, Occhipinti M. Diagnosis and management of hemoptysis. Diagn Interv Radiol. 2014;20(4):299-309.
Ittrich H, Bockhorn M, Klose H, Simon M. The diagnosis and treatment of hemoptysis. Dtsch Arztebl Int. 2017;114(21):371-381.
Taylor SP, Taylor B. Pseudohemoptysis due to Serratia marcescens. J Gen Intern Med. 2014;29(6):962-963.
Mondoni M, Carlucci P, Job S. Observational, multicentre study on the epidemiology of haemoptysis. Eur Respir J. 2018;51(1):1701813.
Seedat UF, Seedat F. Post-primary pulmonary TB haemoptysis—when there is more than meets the eye. Respir Med Case Rep. 2018;25:96-99.
Centers for Disease Control and Prevention. TB risk factors. https://www.cdc.gov/tb/topic/basics/risk.htm
Hu P, Wang G, Cao H, Ma H, Sui P, Du J. Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection. Br J Cancer. 2013;109(6):1609-1617.
Gershman E, Guthrie R, Swiatek K, Shojaee S. Management of hemoptysis in patients with lung cancer. Ann Transl Med. 2019;7(15):358.
American Cancer Society. Lung cancer risk factors. https://www.cancer.org/cancer/lung-cancer/causes-risks-prevention/risk-factors.html
England JH, Byrne DW, Harris BD, Talbot TR. Use of airborne infection isolation in potential cases of pulmonary tuberculosis. Infect Control Hosp Epidemiol. 2020;41(5):505-509.
Ong ZYT, Chai HZ, How CH, Koh J, Low TB. A simplified approach to haemoptysis. Singapore Med J. 2016;57(8):415-418.
Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997;112(2):440-444.
Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 2001;177(4):861-867.
- Mondoni M, Carlucci P, Cipolla G. Bronchoscopy to assess patients with hemoptysis: which is the optimal timing? BMC Pulm Med. 2019;19(1):36.
Mondoni M, Carlucci P, Cipolla G. Long-term prognostic outcomes in patients with haemoptysis. Respir Res. 2021;22(1):219.
Charya AV, Holden VK, Pickering EM. Management of life-threatening hemoptysis in the ICU. J Thorac Dis. 2021;13(8):5139-5158.
Fartoukh M. Severe haemoptysis: indications for triage and admission to hospital or intensive care unit. Rev Mal Respir. 2010;27(10):1243-1253.
Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev. 2016(11):CD008711.
Kathuria H, Hollingsworth HM, Vilvendhan R, Reardon C. Management of life-threatening hemoptysis. J Intensive Care. 2020;8:23.
Choi J, Baik JH, Kim CH. Long-term outcomes and prognostic factors in patients with mild hemoptysis. Am J Emerg Med. 2018;36(7):1160-1165.
Petersen CL, Weinreich UM. Five-year follow-up of hemoptysis with no malignancy suspected on chest computed tomography: recurrence, lung cancer and mortality. Eur Clin Respir J. 2019;6(1):1616519.
